EPHB4 and cancer: Membrane proteins, such as CLDN1, EphB4, and LAT1, were highly expressed in primary CRC and liver metastases, suggesting that CAR-T cell therapy targeting these three cancer antigens could be a viable option, particularly in 30% of cases with reduced HLA class I expression on cancer cell membranes.